WHO ICTRP trial
A Prospective, obServational pOst maRketing survEillance study to evAluate the…
CTRI/2016/12/007566 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2016/12/007566 |
|---|---|
| Public title | A Prospective, obServational pOst maRketing survEillance study to evAluate the effectiveness and safety of secukinumab in Indian patients with moderate to severe pLaque psoriasis (PSO-REAL Study) |
| Scientific title | A Prospective, obServational pOst maRketing survEillance study to evAluate the effectiveness and safety of secukinumab in Indian patients with moderate to severe pLaque psoriasis requiring systemic therapy (PSO-REAL Study) - PSO-REAL study |
| Primary sponsor | Novartis Healthcare Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: null- psoriasis |
| Registration date | Dec 13, 2016 |
| Target size | 72 |
| Secondary IDs | CAIN457AIN01, Version 01 dated 17-Aug-2016 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: